| Efficacy of tocilizumab in patients hospitalized with Covid-19 JH Stone, MJ Frigault, NJ Serling-Boyd, AD Fernandes, L Harvey, ... New England Journal of Medicine 383 (24), 2333-2344, 2020 | 1481 | 2020 |
| Myocarditis in patients treated with immune checkpoint inhibitors SS Mahmood, MG Fradley, JV Cohen, A Nohria, KL Reynolds, ... Journal of the American College of Cardiology 71 (16), 1755-1764, 2018 | 1220 | 2018 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1214 | 2022 |
| Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon TG Neilan, JL Januzzi, E Lee-Lewandrowski, TT Ton-Nu, DM Yoerger, ... Circulation 114 (22), 2325-2333, 2006 | 653 | 2006 |
| Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C … AR Lyon, S Dent, S Stanway, H Earl, C Brezden‐Masley, A Cohen‐Solal, ... European journal of heart failure 22 (11), 1945-1960, 2020 | 515 | 2020 |
| Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis A Di Marco, I Anguera, M Schmitt, I Klem, TG Neilan, JA White, M Sramko, ... JACC: Heart Failure 5 (1), 28-38, 2017 | 382 | 2017 |
| Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque ZD Drobni, RM Alvi, J Taron, A Zafar, SP Murphy, PK Rambarat, ... Circulation 142 (24), 2299-2311, 2020 | 325 | 2020 |
| Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement J Herrmann, D Lenihan, S Armenian, A Barac, A Blaes, D Cardinale, ... European heart journal 43 (4), 280-299, 2022 | 289 | 2022 |
| Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T) RM Alvi, MJ Frigault, MG Fradley, MD Jain, SS Mahmood, M Awadalla, ... Journal of the American College of Cardiology 74 (25), 3099-3108, 2019 | 269 | 2019 |
| Immune checkpoint inhibitor‐associated myocarditis S Ganatra, TG Neilan The oncologist 23 (8), 879-886, 2018 | 261 | 2018 |
| Persistent and reversible cardiac dysfunction among amateur marathon runners TG Neilan, DM Yoerger, PS Douglas, JE Marshall, EF Halpern, D Lawlor, ... European heart journal 27 (9), 1079-1084, 2006 | 260 | 2006 |
| Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis L Zhang, M Awadalla, SS Mahmood, A Nohria, MZO Hassan, F Thuny, ... European heart journal 41 (18), 1733-1743, 2020 | 259 | 2020 |
| T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy CY Ho, SA Abbasi, TG Neilan, RV Shah, Y Chen, B Heydari, AL Cirino, ... Circulation: Cardiovascular Imaging 6 (3), 415-422, 2013 | 254 | 2013 |
| Relation of biomarkers and cardiac magnetic resonance imaging after marathon running N Mousavi, A Czarnecki, K Kumar, N Fallah-Rad, M Lytwyn, SY Han, ... The American journal of cardiology 103 (10), 1467-1472, 2009 | 241 | 2009 |
| CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy TG Neilan, OR Coelho-Filho, SB Danik, RV Shah, JA Dodson, DJ Verdini, ... JACC: Cardiovascular Imaging 6 (9), 944-954, 2013 | 232 | 2013 |
| Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis M Awadalla, SS Mahmood, JD Groarke, MZO Hassan, A Nohria, A Rokicki, ... Journal of the American College of Cardiology 75 (5), 467-478, 2020 | 212 | 2020 |
| Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy TG Neilan, OR Coelho-Filho, RV Shah, JH Feng, D Pena-Herrera, ... The American journal of cardiology 111 (5), 717-722, 2013 | 205 | 2013 |
| Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines TG Neilan, OR Coelho-Filho, D Pena-Herrera, RV Shah, ... The American journal of cardiology 110 (11), 1679-1686, 2012 | 205 | 2012 |
| Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin TG Neilan, SL Blake, F Ichinose, MJ Raher, ES Buys, DS Jassal, ... Circulation 116 (5), 506-514, 2007 | 201 | 2007 |
| Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury TG Neilan, DS Jassal, TM Perez-Sanz, MJ Raher, AD Pradhan, ES Buys, ... European heart journal 27 (15), 1868-1875, 2006 | 190 | 2006 |
